Contacts, documents and full notice history are available with a subscription.

Award Notice 1 notice 1 document

6505--Pluvicto, STL 36C255-25-AP-0008 36C25525N0396

Solicitation 36C25525N0396 Copied Notice ID f671bf2eb8ff4241958f9eb71792e144 Copied VETERANS AFFAIRS, DEPARTMENT OF — 255-NETWORK CONTRACT OFFICE 15 (36C255)

SAM.gov

Posted

Aug 11, 2025

Deadline

No deadline

Set-aside

None

NAICS

325412

PSC

6505

Summary

AI-generated · Aug 24, 2025

Pluvicto (lutetium Lu-177 vipivotide tetraxetan) was awarded to Novartis Pharmaceuticals Corporation for $736,610.

PLUVICTO (lutetium Lu 177 vipivotide tetraxetan).

From Award Notice posted on Aug 11, 2025

Notice history

Award Notice LATEST Posted Aug 11, 2025

Details

Solicitation number 36C25525N0396

Notice ID f671bf2eb8ff4241958f9eb71792e144

Award number 36F79720D018036C25525N0396

Notice type Award Notice

Product / Service (PSC) 6505

NAICS 325412

Archive date Oct 10, 2025

Award Information

Awardee

Total Awarded

$736,610.00

Award Date

Aug 11, 2025

Award Notices

6505--Pluvicto, STL 36C255-25-AP-0008 View Notice

Posted: Aug 11, 2025

PLUVICTO (lutetium Lu 177 vipivotide tetraxetan).

Awardees

Company Name	UEI	CAGE Code	Location
Novartis Pharmaceuticals Corporation	NG61ZA8TADW3	04520	EAST HANOVER

Documents

Document 1

Contacts

primary

Michael Murphy

Contracting Officer

Phone

Agency

VETERANS AFFAIRS, DEPARTMENT OF

255-NETWORK CONTRACT OFFICE 15 (36C255)

Place of Performance

Dates

Posted Aug 11, 2025 11 months ago

Last Updated Aug 06, 2026 2 days ago

Awarded Aug 11, 2025 11 months ago